Multiple drug treatments that increase cAMP signaling restore long-term memory and aberrant signaling in fragile X syndrome models

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

Inositol trisphosphate and calcium signalling

Berridge, M. J. (1993) · Nature · doi:10.1038/361315a0 · Cited by 6,545 · see citing works

The molecular biology of memory storage: a dialogue between genes and synapses

Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · see citing works

Nonparametric Statistics

Siegel, S. (1957) · The American Statistician · doi:10.1080/00031305.1957.10501091 · Cited by 2,792 · see citing works

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works

FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism

Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · see citing works

Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases

Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,352 · see citing works

Altered synaptic plasticity in a mouse model of fragile X mental retardation

Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · see citing works

Classical conditioning and retention in normal and mutantDrosophila melanogaster

Tully, T., & Quinn, W. G. (1985) · Journal of Comparative Physiology A · doi:10.1007/bf01350033 · Cited by 1,189 · see citing works

The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Hallcher, L. M., & Sherman, W. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70391-3 · Cited by 1,102 · see citing works

Fmr1 knockout mice: A model to study fragile X mental retardation

THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,075 · see citing works

Inositol Trisphosphate and Calcium Signaling

Berridge, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26646.x · Cited by 1,031 · see citing works

Neural and developmental actions of lithium: A unifying hypothesis

Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,016 · see citing works

Correction of Fragile X Syndrome in Mice

Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works

Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila

Yin, J. C. P., Wallach, J. S., Del Vecchio, M., Wilder, E. L., Zhou, H., Quinn, W. G., & Tully, T. (1994) · Cell · doi:10.1016/0092-8674(94)90399-9 · Cited by 959 · see citing works

Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function

Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952 · see citing works

Genetic dissection of consolidated memory in Drosophila

Tully, T., Preat, T., Boynton, S. C., & Del Vecchio, M. (1994) · Cell · doi:10.1016/0092-8674(94)90398-0 · Cited by 924 · see citing works

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 833 · see citing works

FMR1 and the fragile X syndrome: Human genome epidemiology review

Crawford, D. C., Acuña, J. M., & Sherman, S. L. (2001) · Genetics in Medicine · doi:10.1097/00125817-200109000-00006 · Cited by 711 · see citing works

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration <i>in vivo</i>

Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · see citing works

Defining the CREB Regulon

Impey, S., McCorkle, S., Cha‐Molstad, H., Dwyer, J. M., Yochum, G. S., Boss, J. M., McWeeney, S. K., Dunn, J. J., Mandel, G., & Goodman, R. H. (2004) · Cell · doi:10.1016/j.cell.2004.10.032 · Cited by 695 · see citing works

The Mating of a Fly

Hall, J. C. (1994) · Science · doi:10.1126/science.8209251 · Cited by 668 · see citing works

Conditioned Behavior in Drosophila melanogaster

Quinn, W. G., Harris, W. A., & Benzer, S. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.708 · Cited by 659 · see citing works

CREB as a Memory Modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in drosophila

Yin, J. C. P., Del Vecchio, M., Zhou, H., & Tully, T. (1995) · Cell · doi:10.1016/0092-8674(95)90375-5 · Cited by 642 · see citing works

Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function

Zhang, Y., Bailey, A. M., Matthies, H. J. G., Renden, R., Smith, M. A., Speese, S. D., Rubin, G. M., & Broadie, K. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00589-x · Cited by 641 · see citing works

Epigenetic Modification of the <i>FMR1</i> Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056

Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., Ramos, F. J., Cornish, K., He, Y., Paulding, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001708 · Cited by 609 · see citing works

Localization of a Short-Term Memory in Drosophila

Zars, T. D., Fischer, M., Schulz, R. A., & Heisenberg, M. (2000) · Science · doi:10.1126/science.288.5466.672 · Cited by 600 · see citing works

Translational Regulatory Mechanisms in Persistent Forms of Synaptic Plasticity

Kelleher, R. J., Govindarajan, A., & Tonegawa, S. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.013 · Cited by 592 · see citing works

Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.

(1994) · PubMed · Cited by 565 · see citing works

Dysregulation of mTOR signaling in fragile X syndrome

Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557 · see citing works

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534 · see citing works

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP

Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · see citing works

Courtship Behavior in Drosophila

Spieth, H. T. (1974) · Annual Review of Entomology · doi:10.1146/annurev.en.19.010174.002125 · Cited by 494 · see citing works

Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice

Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489 · see citing works

Conditioned responses in courtship behavior of normal and mutant Drosophila

Siegel, R. W., & Hall, J. C. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3430 · Cited by 488 · see citing works

Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome

McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D. A., Braunstein, E. M., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.038 · Cited by 473 · see citing works

Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3

Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M. ‐. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 470 · see citing works

Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression

Hou, L., Antion, M. D., Hu, D., Spencer, C. M., Paylor, R., & Klann, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.005 · Cited by 469 · see citing works

CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium

Grimes, C. A., & Jope, R. S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00495.x · Cited by 437 · see citing works

The Courtship of Drosophila Melanogaster

Bastock, M., & Manning, A. (1955) · Behaviour · doi:10.1163/156853955x00184 · Cited by 411 · see citing works

CREB and the formation of long-term memory

Yin, J. C. P., & Tully, T. P. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80082-1 · Cited by 399 · see citing works

Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome

Osterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · see citing works

Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs

Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 377 · see citing works

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial

Martínez, F. J., Calverley, P. M. A., Goehring, U.-M., Brose, M., Fabbri, L. M., & Rabe, K. F. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62410-7 · Cited by 376 · see citing works

Localization of Long-Term Memory Within the Drosophila Mushroom Body

Pascual, A., & Préat, T. (2001) · Science · doi:10.1126/science.1064200 · Cited by 368 · see citing works

Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β

Li, M., Wang, X., Meintzer, M. K., Laessig, T. A., Birnbaum, M. J., & Heidenreich, K. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9356-9363.2000 · Cited by 363 · see citing works

Targeting the CREB pathway for memory enhancers

Tully, T., Bourtchouladze, R., Scott, R., & Tallman, J. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1061 · Cited by 355 · see citing works

The fragile X prevalence paradox

Hagerman, P. J. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059055 · Cited by 343 · see citing works

Deconstructing Memory in Drosophila

Margulies, C. E., Tully, T., & Dubnau, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.08.024 · Cited by 336 · see citing works

MAPK, CREB and zif268 are all required for the consolidation of recognition memory

Bozon, B., Kelly, A. M., Josselyn, S. A., Silva, A. J., Davis, S., & Laroche, S. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2002.1224 · Cited by 327 · see citing works

Experiments on sex recognition and the problem of sexual selection in Drosoophilia.

Sturtevant, A. H. (1915) · Journal of Animal Behavior · doi:10.1037/h0074109 · Cited by 322 · see citing works

Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis

Small, S. A., & Gandy, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.001 · Cited by 320 · see citing works

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

de Vrij, F. M. S., Levenga, J., van der Linde, H. C., Koekkoek, S. K., De Zeeuw, C. I., Nelson, D. L., Oostra, B. A., & Willemsen, R. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.002 · Cited by 313 · see citing works

Lithium, a Common Drug for Bipolar Disorder Treatment, Regulates Amyloid-β Precursor Protein Processing

Yuan, S., Ryder, J. W., Li, B., Wu, X., Fox, N. W., Solenberg, P., Brune, K. A., Paul, S. M., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 295 · see citing works

Metabotropic Receptor-Dependent Long-Term Depression Persists in the Absence of Protein Synthesis in the Mouse Model of Fragile X Syndrome

Nosyreva, E. D., & Huber, K. M. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01316.2005 · Cited by 292 · see citing works

Drosophila Lacking dfmr1 Activity Show Defects in Circadian Output and Fail to Maintain Courtship Interest

Dockendorff, T. C., Su, H. S., McBride, S. M. J., Yang, Z., Choi, C. H., Siwicki, K. K., Sehgal, A., & Jongens, T. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00724-9 · Cited by 284 · see citing works

Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1

Jacquemont, S., Hagerman, R. J., Hagerman, P. J., & Leehey, M. A. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70676-7 · Cited by 277 · see citing works

Inducible Enhancement of Memory Storage and Synaptic Plasticity in Transgenic Mice Expressing an Inhibitor of ATF4 (CREB-2) and C/EBP Proteins

Chen, A. Y.-C., Muzzio, I. A., Malleret, G., Bartsch, D., Verbitsky, M., Pavlidis, P., Yonan, A. L., Vronskaya, S., Grody, M. B., Cepeda, I. L., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00501-4 · Cited by 276 · see citing works

TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model

Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.042 · Cited by 266 · see citing works

Function of the Drosophila CPEB protein Orb2 in long-term courtship memory

Keleman, K., Krüttner, S., Alenius, M., & Dickson, B. J. (2007) · Nature Neuroscience · doi:10.1038/nn1996 · Cited by 266 · see citing works

Mushroom Body Ablation Impairs Short-Term Memory and Long-Term Memory of Courtship Conditioning in Drosophila melanogaster

McBride, S. M. J., Giuliani, G., Choi, C. H., Krause, P., Correale, D., Watson, K. K., Baker, G., & Siwicki, K. K. (1999) · Neuron · doi:10.1016/s0896-6273(00)81043-0 · Cited by 261 · see citing works

Regulation of Eukaryotic Initiation Factor 4E by Converging Signaling Pathways during Metabotropic Glutamate Receptor-Dependent Long-Term Depression

Banko, J. L., Hou, L., Poulin, F., Sonenberg, N., & Klann, E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5196-05.2006 · Cited by 245 · see citing works

A GENE MUTATION WHICH CHANGES A BEHAVIOR PATTERN

Bastock, M. (1956) · Evolution · doi:10.1111/j.1558-5646.1956.tb02868.x · Cited by 243 · see citing works

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240 · cited 1× · see citing works

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment

Pasinetti, G. M., Wang, J., Ho, L., Zhao, W., & Dubner, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.006 · Cited by 238 · see citing works

Drosophila Fragile X Protein, DFXR, Regulates Neuronal Morphology and Function in the Brain

Morales, J., Hiesinger, P. R., Schroeder, A. J., Kume, K., Verstreken, P., Jackson, F. R., Nelson, D. L., & Hassan, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00731-6 · Cited by 238 · see citing works

Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel

Toledano‐Alhadef, H., Basel‐Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321974 · Cited by 228 · see citing works

Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revert

Engel, T., Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04139.x · Cited by 223 · see citing works

Altered Representation of the Spatial Code for Odors after Olfactory Classical Conditioning

Yu, D., Ponomarev, A. L., & Davis, R. L. (2004) · Neuron · doi:10.1016/s0896-6273(04)00217-x · Cited by 222 · see citing works

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

Hashimoto, K., Malchow, B., Falkai, P., & Schmitt, A. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0399-y · Cited by 219 · see citing works

InsP3 Receptor Is Essential for Growth and Differentiation but Not for Vision in Drosophila

Acharya, J., Jalink, K., Hardy, R. W., Hartenstein, V., & Zuker, C. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80328-1 · Cited by 218 · see citing works

Open-Label Treatment Trial of Lithium to Target the Underlying Defect in Fragile X Syndrome

Berry-Kravis, E., Sumis, A., Hervey, C., Nelson, M., Porges, S. W., Weng, N., Weiler, I. J., & Greenough, W. T. (2008) · Journal of Developmental &amp; Behavioral Pediatrics · doi:10.1097/dbp.0b013e31817dc447 · Cited by 215 · see citing works

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits

Christie, S. B., Akins, M. R., Schwob, J. E., & Fallon, J. R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3937-08.2009 · Cited by 208 · see citing works

GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism

Mines, M. A., Yuskaitis, C. J., King, M. K., Beurel, E., & Jope, R. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009706 · Cited by 208 · see citing works

Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome

Hoeffer, C. A., Sanchez, E., Hagerman, R. J., Mu, Y., Nguyen, D. V., Wong, H., Whelan, A. M., Zukin, R. S., Klann, E., & Tassone, F. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00768.x · Cited by 198 · see citing works

BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents

Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · see citing works

Autism and Brain Development

Walsh, C. A., Morrow, E. M., & Rubenstein, J. L. R. (2008) · Cell · doi:10.1016/j.cell.2008.10.015 · Cited by 194 · see citing works

Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory

Bolduc, F. V., Bell, K., Cox, H., Broadie, K. S., & Tully, T. (2008) · Nature Neuroscience · doi:10.1038/nn.2175 · Cited by 187 · see citing works

Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome

Yuskaitis, C. J., Mines, M. A., King, M. K., Sweatt, J. D., Miller, C. A., & Jope, R. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.023 · Cited by 187 · see citing works

Measurement of MAP kinase activation by flow cytometry using phospho‐specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors

Chow, S., Patel, H., & Hedley, D. W. (2001) · Cytometry · doi:10.1002/cyto.1067 · Cited by 181 · see citing works

Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease‐linked APPswe/PS1ΔE9 mice

Hu, Y., Xu, P., Pigino, G. F., Brady, S. T., Larson, J., & Lazarov, O. (2010) · The FASEB Journal · doi:10.1096/fj.09-136945 · Cited by 168 · see citing works

Phosphorylation of the cAMP Response Element Binding Protein CREB by cAMP-Dependent Protein Kinase A and Glycogen Synthase Kinase-3 Alters DNA-Binding Affinity, Conformation, and Increases Net Charge

Bullock, B. P., & Habener, J. F. (1998) · Biochemistry · doi:10.1021/bi970982t · Cited by 167 · see citing works

Functional neuroanatomy of Drosophila olfactory memory formationPreprint

Guven-Ozkan, T., & Davis, R. L. (2014) · Learning & Memory · doi:10.1101/lm.034363.114 · Cited by 166 · see citing works

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

Gurvich, N. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00299-1 · Cited by 162 · see citing works

Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome

Liu, Z., Chuang, D., & Smith, C. B. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000520 · Cited by 159 · see citing works

Cell-type-specific binding of the transcription factor CREB to the cAMP-response element

Cha‐Molstad, H., Keller, D. M., Yochum, G. S., Impey, S., & Goodman, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405587101 · Cited by 148 · see citing works

Prevalence of the fragile X syndrome in African‐Americans

Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Scott, E., Leslie, M., Shubeck, L., Holmgreen, P., Yeargin‐Allsopp, M., Boyle, C. A., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10427 · Cited by 147 · see citing works

Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potential

Min, W. W., Yuskaitis, C. J., Yan, Q., Sikorski, C., Chen, S., Jope, R. S., & Bauchwitz, R. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.017 · Cited by 146 · see citing works

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

Baraban, J. M., Worley, P. F., & Snyder, S. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1251 · Cited by 141 · see citing works

A-Kinase Anchoring Protein AKAP220 Binds to Glycogen Synthase Kinase-3β (GSK-3β) and Mediates Protein Kinase A-dependent Inhibition of GSK-3β

Tanji, C., Yamamoto, H., Yorioka, N., Kohno, N., Kikuchi, K., & Kikuchi, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206210200 · Cited by 140 · see citing works

Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice

Dumont, M., Stack, C., Elipenahli, C., Jainuddin, S., Gerges, M., Starkova, N. N., Yang, L., Starkov, A. A., & Beal, F. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-186650 · Cited by 139 · see citing works

Lithium enhances long‐term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus

Son, H., Yu, I. T., Hwang, S., Kim, J. S., Lee, S., Lee, Y., & Kaang, B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01725.x · Cited by 138 · see citing works

Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice

Billings, L. M., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4800-06.2007 · Cited by 138 · see citing works

Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions

Petry, F. R., Pelletier, J., Bretteville, A., Morin, F., Calon, F., Hébert, S. S., Whittington, R. A., & Planel, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094251 · Cited by 136 · see citing works

Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis

Kavanaugh, A., Mease, P. J., Gómez-Reino, J. J., Adebajo, A., Wollenhaupt, J., Gladman, D. D., Hochfeld, M., Teng, L. L., Schett, G. A., Lespessailles, É., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140647 · Cited by 135 · see citing works

Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3β, Neurotrophin-3 and CREB Signaling

Hu, Y.-S., Long, N., Pigino, G. F., Brady, S. T., & Lazarov, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064460 · Cited by 134 · see citing works

Molecular biology and anatomy of Drosophila olfactory associative learning

Roman, G., & Davis, R. L. (2001) · BioEssays · doi:10.1002/bies.1083 · Cited by 134 · see citing works

An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease

Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133 · cited 1× · see citing works

Cloning and Functional Expression of aDrosophilaMetabotropic Glutamate Receptor Expressed in the Embryonic CNS

Parmentier, M., Pin, J., Bockaert, J., & Grau, Y. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06687.1996 · Cited by 122 · see citing works

Inositol 1,4,5-trisphosphate receptor binding: autoradiographic localization in rat brain

Worley, P. F., Baraban, J. M., & Snyder, S. H. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-01-00339.1989 · Cited by 121 · see citing works

Social structures depend on innate determinants and chemosensory processing in Drosophila

Schneider, J., Dickinson, M. H., & Levine, J. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121252109 · Cited by 115 · see citing works

Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins

Spencer, C. M., Serysheva, E., Yuva‐Paylor, L. A., Oostra, B. A., Nelson, D. L., & Paylor, R. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl121 · Cited by 115 · see citing works

Synaptic Plasticity in Hippocampal CA1 Neurons of Mice Lacking Type 1 Inositol-1,4,5-Trisphosphate ReceptorsPreprint

Fujii, S., Matsumoto, M., Igarashi, K., Kato, H., & Mikoshiba, K. (2000) · Learning & Memory · doi:10.1101/lm.34100 · Cited by 111 · see citing works

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice

Westmark, C. J., Westmark, P. R., O'Riordan, K. J., Ray, B. C., Hervey, C. M., Salamat, M. S., Abozeid, S. H., Stein, K. M., Stodola, L. A., Tranfaglia, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026549 · Cited by 110 · see citing works

Metabolic effects of resveratrol: Addressing the controversies

Bitterman, J. L., & Chung, J. H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1808-8 · Cited by 109 · see citing works

Mapping of the Anatomical Circuit of CaM Kinase-Dependent Courtship Conditioning in DrosophilaPreprint

Joiner, M.-L. A., & Griffith, L. C. (1999) · Learning & Memory · doi:10.1101/lm.6.2.177 · Cited by 107 · see citing works

A Gene Mutation Which Changes a Behavior Pattern

Bastock, M. (1956) · Evolution · doi:10.2307/2407002 · Cited by 105 · see citing works

Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, P., Kollaros, M., Gertner, M. J., Woo, N. H., Tranfaglia, M. R., Bear, M. F., Zukin, R. S., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.032 · Cited by 104 · see citing works

Metabotropic Glutamate Receptor-Mediated LTD Involves Two Interacting Ca2+ Sensors, NCS-1 and PICK1

Jo, J., Seok, H., Kim, M. J., Son, G. H., Park, Y., Henley, J. M., Weiss, J. L., Sheng, M., Collingridge, G. L., & Cho, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.050 · Cited by 97 · see citing works

Understanding fragile X syndrome: insights from animal models

Bakker, C. E., & Oostra, B. A. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072845 · Cited by 87 · see citing works

TheDrosophilaMetabotropic Glutamate Receptor DmGluRA Regulates Activity-Dependent Synaptic Facilitation and Fine Synaptic Morphology

Bogdanik, L. P., Mohrmann, R., Ramaekers, A., Bockaert, J., Grau, Y., Broadie, K. S., & Parmentier, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2724-04.2004 · Cited by 86 · see citing works

The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System

Kelley, D. J., Davidson, R. J., Elliott, J. L., Lahvis, G. P., Yin, J. C. P., & Bhattacharyya, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000931 · Cited by 81 · see citing works

Cyclic AMP metabolism in fragile X syndrome

Berry‐Kravis, E., & Huttenlocher, P. R. (1992) · Annals of Neurology · doi:10.1002/ana.410310105 · Cited by 81 · see citing works

Learning without Performance in PKC-Deficient Drosophila

Kane, N. S., Robichon, A., Dickinson, J. A., & Greenspan, R. J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80270-6 · Cited by 75 · see citing works

Learning and Memory Deficits Consequent to Reduction of the Fragile X Mental Retardation Protein Result from Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling inDrosophila

Kanellopoulos, A. K., Σεμελίδου, Ο., Kotini, A. G., Anezaki, M., & Skoulakis, E. M. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1347-12.2012 · Cited by 72 · see citing works

Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome

Weng, N., Weiler, I. J., Sumis, A. M., Berry‐Kravis, E., & Greenough, W. T. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30765 · Cited by 72 · see citing works

Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP

Kelly, M. P., Isiegas, C., Cheung, Y.-F., Tokarczyk, J., Yang, X., Esposito, M. F., Rapoport, D. A., Fabian, S., Siegel, S. J., Wand, G. S., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301099 · Cited by 71 · see citing works

cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity

Xie, J., Ponuwei, G. A., Moore, C. E., Willars, G. B., Tee, A. R., & Herbert, T. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.025 · Cited by 69 · see citing works

A prospective open-label study of aripiprazole in fragile X syndrome

Erickson, C. A., Stigler, K. A., Wink, L. K., Mullett, J. E., Kohn, A., Posey, D. J., & McDougle, C. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2194-7 · Cited by 69 · see citing works

Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome

Mines, M. A., & Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00035 · Cited by 68 · see citing works

Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling

Pan, L., Woodruff, E. A., Liang, P., & Broadie, K. S. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.01.003 · Cited by 66 · see citing works

Reduced Cyclic AMP Production in Fragile X Syndrome: Cytogenetic and Molecular Correlations

Berry‐Kravis, E., Hicar, M. D., & Ciurlionis, R. (1995) · Pediatric Research · doi:10.1203/00006450-199511000-00002 · Cited by 66 · see citing works

Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome

Liu, Z., Huang, T., & Smith, C. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.037 · Cited by 64 · see citing works

Age-dependent cognitive impairment in a Drosophila Fragile X model and its pharmacological rescue

Choi, C. H., McBride, S. M. J., Schoenfeld, B. P., Liebelt, D. A., Ferreiro, D., Ferrick, N. J., Hinchey, P., Kollaros, M., Ascunce, R. R., Terlizzi, A. M., et al. (2009) · Biogerontology · doi:10.1007/s10522-009-9259-6 · Cited by 62 · see citing works

Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

Kim, S. H., Steele, J., Lee, S. W., Clemenson, G. D., Carter, T., Treuner, K., Gadient, R. A., Wedel, P. C., Glabe, C. G., Barlow, C., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.87 · Cited by 62 · see citing works

Synaptic Defects and Compensatory Regulation of Inositol Metabolism in Inositol Polyphosphate 1-Phosphatase Mutants

Acharya, J., Labarca, P. P., Delgado, R., Jalink, K., & Zuker, C. S. (1998) · Neuron · doi:10.1016/s0896-6273(00)80502-4 · Cited by 59 · see citing works

PDE-4 Inhibition Rescues Aberrant Synaptic Plasticity inDrosophilaand Mouse Models of Fragile X Syndrome

Choi, C. H., Schoenfeld, B. P., Weisz, E. D., Bell, A. J., Chambers, D. B., Hinchey, J., Choi, R. J., Hinchey, P., Kollaros, M., Gertner, M. J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1356-12.2015 · Cited by 57 · see citing works

Short- and Long-Term Memory Are Modulated by Multiple Isoforms of the Fragile X Mental Retardation Protein

Banerjee, P., Schoenfeld, B. P., Bell, A. J., Choi, C. H., Bradley, M. P., Hinchey, P., Kollaros, M., Park, J. H., McBride, S. M. J., & Dockendorff, T. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6369-09.2010 · Cited by 55 · see citing works

Involvement of IP3 receptors in LTP and LTD induction in guinea pig hippocampal CA1 neuronsPreprint

Taufiq, A. M., Fujii, S., Yamazaki, Y., Sasaki, H., Kaneko, K., Li, J., Kato, H., & Mikoshiba, K. (2005) · Learning & Memory · doi:10.1101/lm.17405 · Cited by 55 · see citing works

DrosophilaFragile X Mental Retardation Protein and Metabotropic Glutamate Receptor A Convergently Regulate the Synaptic Ratio of Ionotropic Glutamate Receptor Subclasses

Pan, L., & Broadie, K. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2970-07.2007 · Cited by 54 · see citing works

Gene Expression Profiles in a Transgenic Animal Model of Fragile X Syndrome

D’Agata, V., Warren, S. T., Zhao, W., Torre, E. R., Alkon, D. L., & Cavallaro, S. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0506 · Cited by 54 · see citing works

An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder

Erickson, C. A., Early, M. C., Stigler, K. A., Wink, L. K., Mullett, J. E., & McDougle, C. J. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0034 · Cited by 53 · see citing works

Pharmacodynamic monitoring of BAY 43‐9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells

Tong, F. K., Chow, S., & Hedley, D. W. (2006) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20092 · Cited by 52 · see citing works

Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats

Sugin Lal Jabaris, S., Sumathy, H., Kumar, R. S., Narayanan, S., Thanikachalam, S., & Chidambaram, S. B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.039 · Cited by 47 · see citing works

[3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors

Ornstein, P. L., Arnold, M. B., Bieisch, T. J., Wright, R. A., Wheeler, W. J., & Schoepp, D. D. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00329-1 · Cited by 43 · see citing works

Pharmacological and Genetic Reversal of Age-Dependent Cognitive Deficits Attributable to Decreased presenilin Function

McBride, S. M. J., Choi, C. H., Schoenfeld, B. P., Bell, A. J., Liebelt, D. A., Ferreiro, D. M., Choi, R. J., Hinchey, P., Kollaros, M., Terlizzi, A. M., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1017-10.2010 · Cited by 43 · see citing works

An assay for social interaction in Drosophila fragile X mutants

Bolduc, F. V., Valente, D., Nguyen, A. T., Mitra, P. P., & Tully, T. (2010) · Fly · doi:10.4161/fly.4.3.12280 · Cited by 42 · see citing works

The Neurotransmitter Glutamate Reduces Axonal Responsiveness to Multiple Repellents through the Activation of Metabotropic Glutamate Receptor 1

Kreibich, T. A., Chalasani, S. H., & Raper, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0349-04.2004 · Cited by 42 · see citing works

Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells.

Berry‐Kravis, E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980101)51:1 · Cited by 42 · see citing works

Flies, genes, learning, and memory

Greenspan, R. J. (1995) · Neuron · doi:10.1016/0896-6273(95)90165-5 · Cited by 38 · see citing works

The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free ?-hCG

Spencer, K. (2000) · Prenatal Diagnosis · doi:10.1002/1097-0223(200008)20:8 · Cited by 37 · see citing works

Metabolic benefits of inhibiting cAMP-PDEs with resveratrol

Chung, J. H. (2012) · Adipocyte · doi:10.4161/adip.21158 · Cited by 35 · see citing works

Repetitive exposures to nicotine induce a hyper‐responsiveness via the cAMP/PKA/CREB signal pathway in Drosophila

Hou, J., Kuromi, H., Fukasawa, Y., Ueno, K., Sakai, T., & Kidokoro, Y. (2004) · Journal of Neurobiology · doi:10.1002/neu.20021 · Cited by 35 · see citing works

FMR1 Enhancer Is Regulated by cAMP Through a cAMP-Responsive Element

Hwu, W., WANG, T.-R., & LEE, Y.-M. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.449 · Cited by 30 · see citing works

Inhibitory effects of group II mGluR-related drugs on memory performance in mice

Sato, T., Tanaka, K., Ohnishi, Y., Teramoto, T., Irifune, M., & Nishikawa, T. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2003.12.010 · Cited by 29 · see citing works

Conditions Affecting Social Space in Drosophila melanogaster

McNeil, A. R., Jolley, S. N., Akinleye, A. A., Nurilov, M., Rouzyi, Z., Milunovich, A. J., Chambers, M. C., & Simon, A. F. (2015) · Journal of Visualized Experiments · doi:10.3791/53242 · Cited by 26 · see citing works

Inhibition of GSK-3β enhances reovirus-induced apoptosis in colon cancer cells

Chung (2009) · International Journal of Oncology · doi:10.3892/ijo_00000373 · Cited by 23 · see citing works

The Drosophila DmGluRA is required for social interaction and memory

Schoenfeld, B. P., Choi, R. J., Choi, C. H., Terlizzi, A. M., Hinchey, P., Kollaros, M., Ferrick, N. J., Koenigsberg, E., Ferreiro, D., Leibelt, D. A., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00064 · Cited by 18 · see citing works

Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice

Mines, M. A., Beurel, E., & Jope, R. S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.018 · Cited by 16 · see citing works

Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012

Melancon, B. J., Utley, T. J., Sevel, C., Mattmann, M. E., Cheung, Y., Bridges, T. M., Morrison, R. D., Sheffler, D. J., Niswender, C. M., Daniels, J. S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.018 · Cited by 16 · see citing works

Acute effects of phorbol esters on receptor-mediated IP3, cAMP, and progesterone levels in rat granulosa cells

Davis, J. S., Weakland, L. L., Coffey, R. G., & West, L. A. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.3.e368 · Cited by 16 · see citing works

Untitled work

Turner (1996) · doi:10.1002/(sici)1096-8628(19960712)64:1

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder

Aishworiya, R., Valica, T., Hagerman, R., & Restrepo, B. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01183-1 · Cited by 233 · see citing works

Of Men and Mice: Modeling the Fragile X Syndrome

Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 118 · see citing works

Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome

Thomson, S. R., Seo, S. S., Barnes, S. A., Louros, S. R., Muscas, M., Dando, O., Kirby, C., Wyllie, D. J. A., Hardingham, G. E., Kind, P. C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.013 · Cited by 100 · see citing works

Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders

Telias, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00051 · Cited by 79 · see citing works

Altered dendritic spine function and integration in a mouse model of fragile X syndrome

Booker, S. A., Domanski, A. P. F., Dando, O., Jackson, A. D., Isaac, J. T. R., Hardingham, G. E., Wyllie, D. J. A., & Kind, P. C. (2019) · Nature Communications · doi:10.1038/s41467-019-11891-6 · Cited by 70 · see citing works

Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model

Sethna, F., Feng, W., Ding, Q., Robison, A. J., Feng, Y., & Wang, H. (2017) · Nature Communications · doi:10.1038/ncomms14359 · Cited by 60 · see citing works

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

McCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 57 · see citing works

Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome

Maurin, T., Melancia, F., Jarjat, M., Castro, L. R., Costa, L., Delhaye, S., Khayachi, A., Castagnola, S., Mota, É., Giorgio, A. D., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy192 · Cited by 49 · see citing works

Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome

Costa, L., Sardone, L. M., Bonaccorso, C. M., D’Antoni, S., Spatuzza, M., Gulisano, W., Tropea, M. R., Puzzo, D., Leopoldo, M., Lacivita, E., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00353 · Cited by 49 · see citing works

Negative Effects of Chronic Rapamycin Treatment on Behavior in a Mouse Model of Fragile X Syndrome

Saré, R. M., Song, A., Loutaev, I., Cook, A. K., Maita, I., Lemons, A. H. S., Sheeler, C. A., & Smith, C. B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00452 · Cited by 43 · see citing works

Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder

Long, J., Li, H., Liu, Y., Liao, X., Tang, Z., Han, K., Chen, J., & Zhang, H. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1364858 · Cited by 43 · see citing works

Repurposing available drugs for neurodevelopmental disorders: The fragile X experience

Tranfaglia, M. R., Thibodeaux, C., Mason, D. J., Brown, D., Roberts, I., Smith, R. J., Guilliams, T., & Cogram, P. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.004 · Cited by 39 · see citing works

Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders

D’Antoni, C., Mautone, L., Sanchini, C., Tondo, L., Grassmann, G., Cidonio, G., Bezzi, P., Cordella, F., & Angelantonio, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310762 · Cited by 39 · see citing works

Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects

Malaguarnera, M., Khan, H. Z., & Cauli, O. (2020) · Antioxidants · doi:10.3390/antiox9030188 · Cited by 38 · see citing works

Transcriptomics of Gabra4 knockout mice reveals common NMDAR pathways underlying autism, memory, and epilepsy

Fan, C.-X., Gao, Y., Liang, G., Huang, L., Wang, J., Yang, X., Shi, Y., Dräger, U. C., Zhong, M., Gao, T., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-0318-9 · Cited by 35 · see citing works

Excessive proteostasis contributes to pathology in fragile X syndrome

Louros, S. R., Seo, S. S., Maio, B., Martinez‐Gonzalez, C., Gonzalez‐Lozano, M. A., Muscas, M., Verity, N. C., Wills, J. C., Li, K. W., Nolan, M. F., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.11.012 · Cited by 30 · see citing works

Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs

Roseberry, K., Le-Niculescu, H., Levey, D. F., Bhagar, R., Soe, K. C., Rogers, J., Palkowitz, S., Piña, N. N., Anastasiadis, W. A., Gill, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01998-0 · Cited by 31 · see citing works

Pivotal role of cAMP‐PKA‐CREB signaling pathway in manganese‐induced neurotoxicity in PC12 cells

Yang, Y., Ma, S., Wei, F., Liang, G., Yang, X., Huang, Y., Wang, J., & Zou, Y. (2019) · Environmental Toxicology · doi:10.1002/tox.22776 · Cited by 29 · see citing works

Towards Kinase Inhibitor Therapies for Fragile X Syndrome: Tweaking Twists in the Autism Spectrum Kinase Signaling Network

D’Incal, C., Broos, J., Torfs, T., Kooy, R. F., & Vanden Berghe, W. (2022) · Cells · doi:10.3390/cells11081325 · Cited by 29 · see citing works

Mouse models of fragile X-related disorders

Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 27 · see citing works

Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome

Ciranna, L., & Costa, L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00524 · Cited by 28 · see citing works

Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders

Kaczorowski, J. A., Smith, T. F., Shrewsbury, A. M., Thomas, L. R., Knopik, V. S., & Acosta, M. T. (2020) · Behavior Genetics · doi:10.1007/s10519-020-09991-x · Cited by 24 · see citing works

Systematic Review: Fragile X Syndrome Across the Lifespan with a Focus on Genetics, Neurodevelopmental, Behavioral and Psychiatric Associations

Genovese, A., & Butler, M. G. (2025) · Genes · doi:10.3390/genes16020149 · Cited by 22 · see citing works

An “Omic” Overview of Fragile X Syndrome

Dionne, O., & Corbin, F. (2021) · Biology · doi:10.3390/biology10050433 · Cited by 22 · see citing works

Signaling Pathways Associated with Chronic Wound Progression: A Systems Biology Approach

Basu, P., & Martins‐Green, M. M. (2022) · Antioxidants · doi:10.3390/antiox11081506 · Cited by 20 · see citing works

Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome

Rosenheck, M., Sheeler, C. A., Saré, R. M., Gurney, M. E., & Smith, C. B. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105485 · Cited by 19 · see citing works

Roflumilast and cognition enhancement: A translational perspective

Prickaerts, J., Kerckhoffs, J., Possemis, N., van Overveld, W., Verbeek, F., Grooters, T., Sambeth, A., & Blokland, A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117707 · Cited by 17 · see citing works

Exploring potential mechanism of ciwujia tablets for insomnia by UPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation

Liu, H., Yang, L., Wan, C., Li, Z., Yan, G., Han, Y., Sun, H., & Wang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.990996 · Cited by 17 · see citing works

Persistently Elevated mTOR Complex 1-S6 Kinase 1 Disrupts DARPP-32–Dependent D1 Dopamine Receptor Signaling and Behaviors

Lin, R., Learman, L. N., Na, C. H., Renuse, S., Chen, K. T., Chen, P. Y., Lee, G.-H., Xiao, B., Resnick, S. M., Troncoso, J. C., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.10.012 · Cited by 16 · see citing works

Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19

Sugin Lal Jabaris, S., & Ranju, V. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2020.101978 · Cited by 14 · see citing works

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder

Aishworiya, R., Valica, T., Hagerman, R. J., & Restrepo, B. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.24022006 · Cited by 15 · see citing works

Stress Odorant Sensory Response Dysfunction in Drosophila Fragile X Syndrome Mutants

Androschuk, A., He, R. X., Weber, S. M., Rosenfelt, C. S., & Bolduc, F. V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00242 · Cited by 13 · see citing works

Altered brain serotonin 5-HT1A receptor expression and function in juvenile Fmr1 knockout mice

Saraf, T. S., Chen, Y., Tyagi, R., & Canal, C. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109774 · Cited by 9 · see citing works

Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127

Westmark, P. R., Garrone, B., Ombrato, R., Milanese, C., Giorgio, F. P. D., & Westmark, C. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.751307 · Cited by 9 · see citing works

Modeling neurodegenerative and neurodevelopmental disorders in theDrosophilamushroom bodyPreprint

Stahl, A., & Tomchik, S. M. (2024) · Learning & Memory · doi:10.1101/lm.053816.123 · Cited by 8 · see citing works

From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research

van der Lei, M. B., & Kooy, R. F. (2025) · Biomedicines · doi:10.3390/biomedicines13040805 · Cited by 6 · see citing works

Nutritional status‐dependent endocannabinoid signalling regulates the integration of rat visceral information

Khlaifia, A., Matias, I., Cota, D., & Tell, F. (2017) · The Journal of Physiology · doi:10.1113/jp273484 · Cited by 4 · see citing works

Behavioural difficulties in fragile X syndrome: current pharmacological options and potential future developments

Stanfield, A. C., & McKechanie, A. G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2510408 · Cited by 3 · see citing works

The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder

Thomas, S. D., Mohammed, H. A., Hamad, M. I. K., Öz, M., Statsenko, Y. A., & Sadek, B. S. (2025) · Pharmaceuticals · doi:10.3390/ph18101507 · Cited by 2 · see citing works

FMR1 gene mutations cause neurodevelopmental-degenerative disorders: Importance of fragile X testing in Serbia

Budimirovic, D. B., & Protic, D. D. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp161006315b · Cited by 2 · see citing works

Sleep problems in old age: metabotropic glutamate receptor to the rescue

Inami, S., Afonso, D. J. S., & Koh, K. (2023) · SLEEP · doi:10.1093/sleep/zsad044

Learning-dependent plasticity of the Drosophila mushroom body: An optophysiological approach

Deimel, S. H. (2024) · doi:10.53846/goediss-10629

Dissecting the role of calcium signaling in Fragile X syndrome

Castagnola, S. (2019) · theses.fr (ABES) · doi:10.70675/3d35096bz79d0z46edz8a70zb783a8f60257

Rôle de la phosphodiestérase 2A dans la physiopathologie du syndrome de l’X fragile

Delhaye, S. (2021) · doi:10.70675/e0fac395z63d4z46a4z944aza4037215ca98

Dopamine and non-canonical signaling

Mota, É. (2019) · doi:10.70675/b52063b9zafc7z425fzb014z38760aab3078

Developmental lithium exposure and neurodevelopment: Epidemiological evidence, biological pathways, and implications for autism

Kim, J., Hwang, S.-H., Matson, C. W., Brooks, B. W., & Shin, H. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.142590

PDE-4 Inhibition Rescues Aberrant Synaptic Plasticity inDrosophilaand Mouse Models of Fragile X Syndrome

Choi, C. H., Schoenfeld, B. P., Weisz, E. D., Bell, A. J., Chambers, D. B., Hinchey, J., Choi, R. J., Hinchey, P., Kollaros, M., Gertner, M. J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1356-12.2015 · Cited by 57 · see citing works

Learning and Memory Deficits Consequent to Reduction of the Fragile X Mental Retardation Protein Result from Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling inDrosophila

Kanellopoulos, A. K., Σεμελίδου, Ο., Kotini, A. G., Anezaki, M., & Skoulakis, E. M. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1347-12.2012 · Cited by 72 · see citing works

The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System

Kelley, D. J., Davidson, R. J., Elliott, J. L., Lahvis, G. P., Yin, J. C. P., & Bhattacharyya, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000931 · Cited by 81 · see citing works

How close are we to a cAMP- and cGMP-theory-based pharmacological therapy for fragile X syndrome?

Bardoni, B., Gwizdek, C., & Maurin, T. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101972 · Cited by 3 · see citing works

Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment

Choi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, P., Kollaros, M., Gertner, M. J., Woo, N. H., Tranfaglia, M. R., Bear, M. F., Zukin, R. S., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.032 · Cited by 104 · see citing works